FATE
FATE THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$2.09
+2.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 62.70x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.63x
- Price / sales
- 38.58x
- Price / cash flow
- -2.46x
Enterprise value
- Enterprise value
- $172.3M
- EV / sales
- 26.55x
- EV / EBITDA
- -1.51x
- EV / EBIT
- -1.29x
- Market cap
- $250.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026